CONMED Long Term Debt 2010-2022 | CNMD

CONMED long term debt from 2010 to 2022. Long term debt can be defined as the sum of all long term debt fields.
CONMED Annual Long Term Debt
(Millions of US $)
2021 $672
2020 $735
2019 $755
2018 $439
2017 $472
2016 $488
2015 $269
2014 $240
2013 $214
2012 $161
2011 $89
2010 $85
2009 $182
CONMED Quarterly Long Term Debt
(Millions of US $)
2022-06-30 $982
2022-03-31 $704
2021-12-31 $672
2021-09-30 $703
2021-06-30 $708
2021-03-31 $725
2020-12-31 $735
2020-09-30 $760
2020-06-30 $790
2020-03-31 $773
2019-12-31 $755
2019-09-30 $781
2019-06-30 $796
2019-03-31 $804
2018-12-31 $439
2018-09-30 $443
2018-06-30 $432
2018-03-31 $442
2017-12-31 $472
2017-09-30 $495
2017-06-30 $484
2017-03-31 $487
2016-12-31 $488
2016-09-30 $490
2016-06-30 $509
2016-03-31 $512
2015-12-31 $269
2015-09-30 $261
2015-06-30 $259
2015-03-31 $257
2014-12-31 $240
2014-09-30 $247
2014-06-30 $245
2014-03-31 $241
2013-12-31 $214
2013-09-30 $224
2013-06-30 $233
2013-03-31 $225
2012-12-31 $161
2012-09-30 $168
2012-06-30 $145
2012-03-31 $139
2011-12-31 $89
2011-09-30 $9
2011-06-30 $31
2011-03-31 $72
2010-12-31 $85
2010-09-30 $171
2010-06-30 $170
2010-03-31 $174
2009-12-31 $182
2009-09-30 $183
2009-06-30 $184
2009-03-31 $187
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $3.073B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $73.740B 21.42
McKesson (MCK) United States $51.687B 15.01
AmerisourceBergen (ABC) United States $30.494B 13.47
West Pharmaceutical Services (WST) United States $25.090B 38.20
Laboratory Of America Holdings (LH) United States $24.019B 10.51
Cardinal Health (CAH) United States $17.095B 13.13
Cooper (COO) United States $16.392B 25.23
Invacare (IVC) United States $0.035B 0.00